Replay available

NeOnc Technologies Holdings, Inc. (NTHI) Q2 2026 Earnings Call

NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) Q2 2026 earnings conference call, held 2026-08-12. Replay captured from the company's public earnings webcast.

Wed, August 12, 2026 at 5:00 PMendedReplay
NeOnc Technologies Holdings, Inc. (NTHI) Q2 2026 Earnings Call

Hosted by

Featured presenters

Dr. Miller

Key Opinion Leader, Neuro-Oncology

Dr. Josh Neman

Chief Clinical Officer

Dr. Frantz

Key Opinion Leader, Neuro-Oncology

Dr. Thomas Chen

Founder, Chief Medical Officer & Chief Scientific Officer

Amir Heshmatpour

Chief Executive Officer & Executive Chairman

Keithly Garnett

Chief Financial Officer

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Neonc Technologies Holdings, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.373 Good morning, everyone. Welcome to the Neon Technologies Investment Conference, Paul, 00:00:05.373 -- 00:00:10.894 to discuss top-line results from the Phase 2845 of our NEO100-01 00:00:10.894 -- 00:00:15.876 clinical style, the recurrent IDH1-Newton's 00:00:15.876 -- 00:00:18.496 high-grade glioma. 00:00:20.017 -- 00:00:25.038 Joining me on the call today, we have Amir Heshmatpour, our 00:00:25.038 -- 00:00:29.217 Chief Executive Officer and Executive Chairman, We also have Dr. 00:00:29.217 -- 00:00:34.118 Thomas Chen to my right, who's our founder and chief medical officer and chief scientific 00:00:34.118 -- 00:00:39.219 officer. We also have Dr. Josh Neman, who's our chief clinical 00:00:39.219 -- 00:00:44.561 officer. My name is Keithly Garnett. I serve as the chief financial officer. 00:00:44.561 -- 00:00:47.541 Today, we're also joined by one of our board members, Mr. 00:00:47.541 -- 00:00:53.742 Mayor Jim Delshad, and other board members are participating through the webcast. 00:00:54.963 -- 00:01:00.113 Before we begin, I would like to remind everyone that during this call, we will 00:01:00.113 -- 00:01:05.454 make forward-looking statements within the meeting of Section 27A of the Securities 00:01:05.454 -- 00:01:07.674 Act of 1933 00:01:07.674 -- 00:01:12.636 and Section 21E of the Securities Act of 1934. 00:01:12.636 -- 00:01:18.257 These statements can be identified by words such as may, will, 00:01:18.257 -- 00:01:20.597 should, intend, 00:01:20.617 -- 00:01:24.564 expect, plan, anticipate, 00:01:24.564 -- 00:01:29.688 believe, estimate, predict, potential, continue, 00:01:29.688 -- 00:01:32.890 evaluating, and other similar terms. 00:01:32.890 -- 00:01:35.973 These statements reflect our current expectations 00:01:35...